The GLIOMAX Study: MT027 Allogeneic CAR-T for Recurrent Glioma
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Kuo-Chen Wei, MD
Chang Gung Memorial Hospital
Principal Investigator - Solmaz Sahebjam, MD
The Johns Hopkins Cancer Center, Sibley Memorial Hospital
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
4 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Hualien Tzu Chi Hospital
Hualien City, Taiwan
Shinn-Zong Lin, MD, PhD - Chang Gung Memorial Hospital, Kaohsiung
Kaohsiung City, Taiwan
Fu-Yuan Shih, MD - Chang Gung Memorial Hospital, Linkou
Taoyuan, Taiwan
Kuo-Chen Wei, MD
- the Johns Hopkins Sidney Kimmel Cancer Center
Baltimore, Maryland, United States
Solmaz Sahebjam, MD
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Jun 2026
- Primary completion
- 13 Dec 2028
- Completion
- 31 Jul 2029
- Last update posted
- 10 Feb 2026
- Registered enrollment
- 40
- Registry id
- NCT07386002
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.